US20040194793A1 - Coated nicotine-containing chewing gum, manufacture and use thereof - Google Patents

Coated nicotine-containing chewing gum, manufacture and use thereof Download PDF

Info

Publication number
US20040194793A1
US20040194793A1 US10/481,053 US48105304A US2004194793A1 US 20040194793 A1 US20040194793 A1 US 20040194793A1 US 48105304 A US48105304 A US 48105304A US 2004194793 A1 US2004194793 A1 US 2004194793A1
Authority
US
United States
Prior art keywords
nicotine
chewing gum
subject
coating
product according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US10/481,053
Other languages
English (en)
Inventor
Katarina Lindell
Nils-Olof Lindberg
Roland Olsson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
McNeil AB
Original Assignee
Pharmacia AB
McNeil AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia AB, McNeil AB filed Critical Pharmacia AB
Assigned to PHARMACIA AB reassignment PHARMACIA AB ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: LINDBERG, NILS-OLOF, LINDELL, KATARINA, OLSSON, ROLAND
Publication of US20040194793A1 publication Critical patent/US20040194793A1/en
Assigned to MCNEIL AB reassignment MCNEIL AB ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: PFIZER HEALTH AB, PHARMACIA AB
Priority to US13/249,619 priority Critical patent/US20120017924A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G4/00—Chewing gum
    • A23G4/06—Chewing gum characterised by the composition containing organic or inorganic compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23B—PRESERVING, e.g. BY CANNING, MEAT, FISH, EGGS, FRUIT, VEGETABLES, EDIBLE SEEDS; CHEMICAL RIPENING OF FRUIT OR VEGETABLES; THE PRESERVED, RIPENED, OR CANNED PRODUCTS
    • A23B4/00—General methods for preserving meat, sausages, fish or fish products
    • A23B4/10—Coating with a protective layer; Compositions or apparatus therefor
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G4/00—Chewing gum
    • A23G4/02—Apparatus specially adapted for manufacture or treatment of chewing gum
    • A23G4/04—Apparatus specially adapted for manufacture or treatment of chewing gum for moulding or shaping
    • A23G4/043—Apparatus specially adapted for manufacture or treatment of chewing gum for moulding or shaping for composite chewing gum
    • A23G4/046—Apparatus specially adapted for manufacture or treatment of chewing gum for moulding or shaping for composite chewing gum with a centre made of chewing gum
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G4/00—Chewing gum
    • A23G4/06—Chewing gum characterised by the composition containing organic or inorganic compounds
    • A23G4/12—Chewing gum characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins
    • A23G4/126—Chewing gum characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins containing vitamins, antibiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G4/00—Chewing gum
    • A23G4/18—Chewing gum characterised by shape, structure or physical form, e.g. aerated products
    • A23G4/20—Composite products, e.g. centre-filled, multi-layer, laminated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A61K9/0058—Chewing gums
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
US10/481,053 2001-06-20 2002-06-14 Coated nicotine-containing chewing gum, manufacture and use thereof Abandoned US20040194793A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US13/249,619 US20120017924A1 (en) 2001-06-20 2011-09-30 Coated nicotine-containing chewing gum, manufacture and use thereof

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0102197A SE0102197D0 (sv) 2001-06-20 2001-06-20 New product and use and manufacture thereof
SE0102197-1 2001-06-20
PCT/SE2002/001158 WO2002102357A1 (en) 2001-06-20 2002-06-14 A coated nicotine-containing chewing gum, manufacture and use thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US13/249,619 Continuation US20120017924A1 (en) 2001-06-20 2011-09-30 Coated nicotine-containing chewing gum, manufacture and use thereof

Publications (1)

Publication Number Publication Date
US20040194793A1 true US20040194793A1 (en) 2004-10-07

Family

ID=20284551

Family Applications (2)

Application Number Title Priority Date Filing Date
US10/481,053 Abandoned US20040194793A1 (en) 2001-06-20 2002-06-14 Coated nicotine-containing chewing gum, manufacture and use thereof
US13/249,619 Abandoned US20120017924A1 (en) 2001-06-20 2011-09-30 Coated nicotine-containing chewing gum, manufacture and use thereof

Family Applications After (1)

Application Number Title Priority Date Filing Date
US13/249,619 Abandoned US20120017924A1 (en) 2001-06-20 2011-09-30 Coated nicotine-containing chewing gum, manufacture and use thereof

Country Status (19)

Country Link
US (2) US20040194793A1 (es)
EP (1) EP1404306B1 (es)
JP (2) JP4571402B2 (es)
AR (1) AR034527A1 (es)
AT (1) ATE485034T1 (es)
AU (1) AU2002345454B2 (es)
BR (1) BR0210342A (es)
CA (1) CA2449298C (es)
CZ (1) CZ20033458A3 (es)
DE (1) DE60238054D1 (es)
DK (1) DK1404306T3 (es)
ES (1) ES2352681T3 (es)
IL (2) IL159425A0 (es)
MX (1) MXPA03011557A (es)
NZ (1) NZ529780A (es)
RU (1) RU2291688C2 (es)
SE (1) SE0102197D0 (es)
WO (1) WO2002102357A1 (es)
ZA (1) ZA200309204B (es)

Cited By (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060275344A1 (en) * 2005-05-18 2006-12-07 Seema Mody Flavoring of drug-containing chewing gums
US20070071710A1 (en) * 2005-09-23 2007-03-29 Chanel Parfums Beaute Extract of vanilla planifolia
US20070269492A1 (en) * 2006-05-16 2007-11-22 Per Steen New product and use and manufacture thereof
US20080260825A1 (en) * 2007-04-02 2008-10-23 Maryka Quik Methods and Compositions for Reduction of Side Effects of Therapeutic Treatments
US20090196834A1 (en) * 2004-06-29 2009-08-06 Carsten Andersen Tobacco alkaloid releasing chewing gum
WO2009141321A2 (en) * 2008-05-21 2009-11-26 Novartis Ag Tablettable chewing gums
US20100061940A1 (en) * 2006-03-16 2010-03-11 Niconovum Ab Chewing Gum Compositions Providing Rapid Release of Nicotine
US20100260690A1 (en) * 2007-09-18 2010-10-14 Arne Kristensen Stable chewing gum compositions comprising maltitol and providing rapid release of nicotine
US20110214681A1 (en) * 2008-09-17 2011-09-08 Niconovum Ab Process for preparing snuff composition
WO2011139684A2 (en) 2010-04-28 2011-11-10 Niconovum Usa, Inc. Nicotine-containing pharmaceutical compositions
WO2011139811A1 (en) 2010-05-07 2011-11-10 Niconovum Usa, Inc. Nicotine-containing pharmaceutical compositions
US20110318391A1 (en) * 2010-06-28 2011-12-29 Fuisz Richard C Bioactive Dose Having Containing a Material for Modulating pH of a Bodily Fluid to Help or Hinder Absorption of a Bioactive
WO2013059592A1 (en) 2011-10-21 2013-04-25 Niconovum Usa, Inc. Excipients for nicotine-containing therapeutic compositions
US8642016B2 (en) 2006-07-21 2014-02-04 Jsrnti, Llc Medicinal delivery system, and related methods
US20140261505A1 (en) * 2011-10-19 2014-09-18 Vivi Bjerre Jorgensen Nicotine Chewing Gum With Improved Utilization Of Nicotine
US9402809B2 (en) 2006-03-16 2016-08-02 Niconovum Usa, Inc. Snuff composition
US9629832B2 (en) 2002-12-20 2017-04-25 Niconovum Usa, Inc. Physically and chemically stable nicotine-containing particulate material
WO2017098443A1 (en) 2015-12-10 2017-06-15 Niconovum Usa, Inc. Protein-enriched therapeutic composition of a nicotinic compound
US9700525B2 (en) 2008-08-20 2017-07-11 Board Of Supervisors Of Louisiana State University And Agricultural & Mechanical College Continuous local slow-release of therapeutics for head and neck problems and upper aerodigestive disorders
US9744128B2 (en) * 2014-06-05 2017-08-29 Mastix LLC Method for manufacturing medicated chewing gum without cooling
US10130120B2 (en) 2013-03-15 2018-11-20 Altria Client Services Llc Use of pectin or other anionic polymers in the stabilization and controlled release of nicotine in oral sensorial tobacco products or nicotine containing non-tobacco oral sensorial products
CN108991596A (zh) * 2018-10-11 2018-12-14 玉溪开元金蓝生物科技有限责任公司 复方滇橄榄添加料、制备方法及其在香烟滤嘴棒上的应用
US10213586B2 (en) 2015-01-28 2019-02-26 Chrono Therapeutics Inc. Drug delivery methods and systems
US10258778B2 (en) 2004-09-13 2019-04-16 Chrono Therapeutics Inc. Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like
CN110367592A (zh) * 2013-07-19 2019-10-25 奥驰亚客户服务有限责任公司 电子吸烟器具的液体气溶胶制剂
WO2019239356A1 (en) 2018-06-15 2019-12-19 R. J. Reynolds Tobacco Company Purification of nicotine
US10653686B2 (en) 2011-07-06 2020-05-19 Parkinson's Institute Compositions and methods for treatment of symptoms in parkinson's disease patients
US10679516B2 (en) 2015-03-12 2020-06-09 Morningside Venture Investments Limited Craving input and support system
US10716764B2 (en) 2003-10-27 2020-07-21 Morningside Venture Investments Limited Transdermal drug delivery method and system
EP3445344B1 (en) 2016-04-21 2020-08-19 Fertin Pharma A/S Nicotine delivery product, related uses and oral dosage forms, and methods of production
CN112367978A (zh) * 2018-07-13 2021-02-12 麦克内尔股份公司 包含尼古丁的口香糖
US20210045430A1 (en) * 2008-12-19 2021-02-18 U.S. Smokeless Tobacco Company Llc Tobacco granules and method of producing tobacco granules
US11077089B2 (en) 2016-06-22 2021-08-03 Per Os Biosciences, Llc Oral compositions delivering therapeutically effective amounts of cannabinoids
US11285306B2 (en) 2017-01-06 2022-03-29 Morningside Venture Investments Limited Transdermal drug delivery devices and methods
CN114945359A (zh) * 2020-01-15 2022-08-26 麦克内尔股份公司 口香糖的产品和制备方法
US11596779B2 (en) 2018-05-29 2023-03-07 Morningside Venture Investments Limited Drug delivery methods and systems

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0302947D0 (sv) 2003-01-24 2003-11-07 Magle Ab A composition material for transmucosal delivery
SI1617823T1 (sl) * 2003-01-24 2019-07-31 Nicachet Ab Vrečka, ki obsega nikotinski sestavek za transmukozno dajanje
ES2291621T5 (es) * 2003-02-04 2012-11-08 Gumlink A/S Pastilla de goma de mascar comprimida
EP1449525A1 (en) * 2003-02-20 2004-08-25 Cross Chem Llc chewing gum in the form of multi-layer tablets
AU2005272802B2 (en) * 2004-08-11 2009-07-02 Intercontinental Great Brands Llc Sensate compositions and delivery systems therefor
MX2007004045A (es) 2004-10-08 2007-06-07 Gumlink As Producto de confiteria.
WO2006058536A1 (en) 2004-11-30 2006-06-08 Fertin Pharma A/S Method of providing fast relief to a user of a nicotine chewing gum
US8024911B2 (en) 2006-02-16 2011-09-27 Mcneil Ab Method for blister packing
US20070269386A1 (en) 2006-05-16 2007-11-22 Per Steen New product and use and manufacture thereof
AU2012241150B2 (en) * 2006-07-21 2015-04-16 Jsrnti, Llc Medicinal delivery system and related methods
NZ579205A (en) * 2007-02-26 2012-03-30 Revolymer Ltd Chewing gum containing an amphiphilic polymer which controls the release of a drug or other biologically active material
US20080286340A1 (en) * 2007-05-16 2008-11-20 Sven-Borje Andersson Buffered nicotine containing products
US20080286341A1 (en) * 2007-05-16 2008-11-20 Sven-Borje Andersson Buffered coated nicotine containing products
JP2009102287A (ja) * 2007-10-19 2009-05-14 Seiji Sakao 禁煙用の辛い唐辛子
EP2229156B1 (en) 2007-12-20 2016-11-09 Fertin Pharma A/S Chewing gum tablet and method of dosing pharmaceutically active ingredients in such chewing gum tablet
WO2009080021A1 (en) 2007-12-20 2009-07-02 Fertin Pharma A/S Compressed chewing gum tablet
EP2229158B1 (en) 2007-12-20 2016-08-10 Fertin Pharma A/S Compressed chewing gum tablet
AR071420A1 (es) 2008-05-01 2010-06-16 Smithkline Beecham Corp Composicion de pastilla para chupar oral que comprende un principio activo de nicotina y procedimiento para fabricarla
EP2282645B1 (en) 2008-05-26 2015-04-15 Fertin Pharma A/S Flavor impregnation of a chewing gum core
AU2009303979A1 (en) * 2008-10-14 2010-04-22 Mcneil Ab Multi portion intra-oral dosage form and use thereof
US8506936B2 (en) * 2008-11-25 2013-08-13 Watson Laboratories, Inc. Stabilized nicotine chewing gum
EP2373179B1 (en) 2008-12-19 2018-08-01 Fertin Pharma A/S Multi-part kit comprising a chewing gum and further a flavor containing formulation
EP2233134A1 (en) * 2009-03-27 2010-09-29 McNeil AB Multi-portion intra-oral dosage form with organoleptic properties
WO2010145653A1 (en) 2009-06-19 2010-12-23 Fertin Pharma A/S Buffered gum base for high ph release
RU2417095C1 (ru) * 2010-02-12 2011-04-27 Александр Ицхокович Кашлинский Средство "куримало" ("км"), снижающее тягу к курению
US20130177646A1 (en) * 2012-01-05 2013-07-11 Mcneil Ab Solid Nicotine-Comprising Dosage Form with Reduced Organoleptic Disturbance
CN103478893B (zh) * 2013-09-09 2016-02-10 湖南中烟工业有限责任公司 茶氨酸在胶基咀嚼型无烟气烟草制品中的应用
JP6682450B2 (ja) 2014-04-08 2020-04-15 フェルティン ファルマ アー／エス 医療用チューインガム
US10632076B2 (en) 2016-11-18 2020-04-28 Fertin Pharma A/S Tablet comprising separate binder and erythritol
US10543205B2 (en) 2016-11-18 2020-01-28 Fertin Pharma A/S Oral delivery vehicle containing nicotine
SE541358C2 (en) 2017-05-30 2019-08-13 Enorama Pharma Ab Nicotine-containing chewing gum compositions
US11135157B2 (en) 2018-05-17 2021-10-05 Fertin Pharma A/S Oral tablet for delivery of active ingredients to the throat
US11058633B2 (en) 2018-05-17 2021-07-13 Fertin Pharma A/S Disintegrating oral tablet suitable for active pharmaceutical ingredients
JP7214755B2 (ja) * 2018-05-17 2023-01-30 フェルティン ファルマ アー／エス 医薬品活性成分に適した錠剤化チューインガム
US11096896B2 (en) 2018-05-17 2021-08-24 Fertin Pharma A/S Tablet dosage form for buccal absorption of active ingredients
US20190350858A1 (en) 2018-05-17 2019-11-21 Fertin Pharma A/S Oral tablet for delivery of active ingredients to the gastrointestinal tract
US11058641B2 (en) 2018-05-17 2021-07-13 Fertin Pharma A/S Oral tablet for taste masking of active ingredients
US11096895B2 (en) * 2018-05-17 2021-08-24 Fertin Pharma A/S Oral tablet suitable for active pharmaceutical ingredients
US11052047B2 (en) 2018-05-17 2021-07-06 Fertin Pharma A/S Oral tablet suitable for fast release of active pharmaceutical ingredients
US11090263B2 (en) 2018-05-22 2021-08-17 Fertin Pharma A/S Tableted chewing gum suitable for active pharmaceutical ingredients
US11096894B2 (en) 2018-05-17 2021-08-24 Fertin Pharma A/S Oral tablet for induced saliva generation
WO2022224200A1 (en) * 2021-04-22 2022-10-27 Nicoventures Trading Limited Oral compositions and methods of manufacture

Citations (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3845217A (en) * 1972-11-16 1974-10-29 Helsingborg L Ab Buffered smoking substitute compositions
US3877468A (en) * 1970-07-22 1975-04-15 Leo Ab Chewable tobacco substitute composition
US3901248A (en) * 1970-07-22 1975-08-26 Leo Ab Chewable smoking substitute composition
US4579858A (en) * 1983-01-21 1986-04-01 Aktiebolaget Leo Smoking substitutes for nasal administration-I
US4920989A (en) * 1985-04-25 1990-05-01 Regents Of The University Of California Method and apparatus for aiding in the reduction of incidence of tobacco smoking
US4967773A (en) * 1986-06-26 1990-11-06 Shaw Alec S W Nicotine containing lozenge
US5057328A (en) * 1988-11-14 1991-10-15 Warner-Lambert Company Food acid delivery systems containing polyvinyl acetate
US5154939A (en) * 1989-04-19 1992-10-13 Wm. Wrigley Jr. Company Use of salt to improve extrusion encapsulation of chewing gum ingredients
US5167242A (en) * 1990-06-08 1992-12-01 Kabi Pharmacia Aktiebolaq Nicotine-impermeable container and method of fabricating the same
US5549906A (en) * 1993-07-26 1996-08-27 Pharmacia Ab Nicotine lozenge and therapeutic method for smoking cessation
US5656255A (en) * 1992-01-03 1997-08-12 Pharmacia & Upjohn Ab Composition to help stop smoking
US5721257A (en) * 1993-08-04 1998-02-24 Pharmacia & Upjohn Ab Method and therapeutic system for smoking cessation
US5810018A (en) * 1994-12-29 1998-09-22 Monte; Woodrow C. Method, composition and apparatus for reducing the incidence of cigarette smoking
US5939100A (en) * 1993-11-01 1999-08-17 Pharmacia And Upjohn Ab Composition for drug delivery comprising nicotine or a derivative thereof and starch microspheres and method for the manufacturing thereof
US5955098A (en) * 1996-04-12 1999-09-21 Flemington Pharmaceutical Corp. Buccal non polar spray or capsule
US5972974A (en) * 1993-02-02 1999-10-26 Pharmaco Behavioral Associates, Inc. Transdermal nicotine metabolites and human body weight
US6024097A (en) * 1992-02-20 2000-02-15 J Mom Trust Product for assisting a smoker in giving up the habit
US6183775B1 (en) * 1996-05-13 2001-02-06 Novartis Consumer Health S.A. Buccal delivery system
US6413496B1 (en) * 1996-12-04 2002-07-02 Biogland Ireland (R&D) Limited Pharmaceutical compositions and devices for their administration
US6586023B1 (en) * 1998-12-15 2003-07-01 Wm. Wrigley Jr. Company Process for controlling release of active agents from a chewing gum coating and product thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4366211A (en) 1981-09-21 1982-12-28 Westinghouse Electric Corp. Control of electrolyte fill to fuel cell stack
GB2289204B (en) * 1994-04-21 1998-01-14 Williamson Research Limited A chewing gum for use as a nicotine substitute and slimming aid
DK0745380T3 (da) * 1995-05-11 2005-12-05 Univ Utah Res Found Tobakserstatning
WO2000035296A1 (en) * 1996-11-27 2000-06-22 Wm. Wrigley Jr. Company Improved release of medicament active agents from a chewing gum coating
EP0969733B1 (en) 1996-11-27 2006-06-21 Wm. Wrigley Jr. Company Method of controlling release of caffeine in chewing gum and gum produced thereby
EP1107730B1 (en) * 1998-09-03 2008-03-12 Jsr Nti Llc Medicated chewing gum delivery system for nicotine
WO2000019977A1 (en) 1998-10-08 2000-04-13 Biovail Technologies Ltd. Composition and method for medicated chewing gum delivery system
CA2366845A1 (en) 1999-03-22 2000-09-28 Atp Avant-Garde Technologies & Product Marketing & Licensing S.A. Composition for medicated chewing gums, process for manufacturing the same and tablets so obtained

Patent Citations (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3877468A (en) * 1970-07-22 1975-04-15 Leo Ab Chewable tobacco substitute composition
US3901248A (en) * 1970-07-22 1975-08-26 Leo Ab Chewable smoking substitute composition
US3845217A (en) * 1972-11-16 1974-10-29 Helsingborg L Ab Buffered smoking substitute compositions
US4579858A (en) * 1983-01-21 1986-04-01 Aktiebolaget Leo Smoking substitutes for nasal administration-I
US4920989A (en) * 1985-04-25 1990-05-01 Regents Of The University Of California Method and apparatus for aiding in the reduction of incidence of tobacco smoking
US4967773A (en) * 1986-06-26 1990-11-06 Shaw Alec S W Nicotine containing lozenge
US5057328A (en) * 1988-11-14 1991-10-15 Warner-Lambert Company Food acid delivery systems containing polyvinyl acetate
US5154939A (en) * 1989-04-19 1992-10-13 Wm. Wrigley Jr. Company Use of salt to improve extrusion encapsulation of chewing gum ingredients
US5167242A (en) * 1990-06-08 1992-12-01 Kabi Pharmacia Aktiebolaq Nicotine-impermeable container and method of fabricating the same
US5656255A (en) * 1992-01-03 1997-08-12 Pharmacia & Upjohn Ab Composition to help stop smoking
US6024097A (en) * 1992-02-20 2000-02-15 J Mom Trust Product for assisting a smoker in giving up the habit
US5972974A (en) * 1993-02-02 1999-10-26 Pharmaco Behavioral Associates, Inc. Transdermal nicotine metabolites and human body weight
US5549906A (en) * 1993-07-26 1996-08-27 Pharmacia Ab Nicotine lozenge and therapeutic method for smoking cessation
US5721257A (en) * 1993-08-04 1998-02-24 Pharmacia & Upjohn Ab Method and therapeutic system for smoking cessation
US5939100A (en) * 1993-11-01 1999-08-17 Pharmacia And Upjohn Ab Composition for drug delivery comprising nicotine or a derivative thereof and starch microspheres and method for the manufacturing thereof
US5810018A (en) * 1994-12-29 1998-09-22 Monte; Woodrow C. Method, composition and apparatus for reducing the incidence of cigarette smoking
US5955098A (en) * 1996-04-12 1999-09-21 Flemington Pharmaceutical Corp. Buccal non polar spray or capsule
US6183775B1 (en) * 1996-05-13 2001-02-06 Novartis Consumer Health S.A. Buccal delivery system
US6413496B1 (en) * 1996-12-04 2002-07-02 Biogland Ireland (R&D) Limited Pharmaceutical compositions and devices for their administration
US6586023B1 (en) * 1998-12-15 2003-07-01 Wm. Wrigley Jr. Company Process for controlling release of active agents from a chewing gum coating and product thereof

Cited By (71)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9629832B2 (en) 2002-12-20 2017-04-25 Niconovum Usa, Inc. Physically and chemically stable nicotine-containing particulate material
US10716764B2 (en) 2003-10-27 2020-07-21 Morningside Venture Investments Limited Transdermal drug delivery method and system
US8828361B2 (en) 2004-06-29 2014-09-09 Fertin Pharma A/S Tobacco alkaloid releasing chewing gum
US20090196834A1 (en) * 2004-06-29 2009-08-06 Carsten Andersen Tobacco alkaloid releasing chewing gum
US8529875B2 (en) * 2004-06-29 2013-09-10 Fertin Pharma A/S Tobacco alkaloid releasing chewing gum
US10258778B2 (en) 2004-09-13 2019-04-16 Chrono Therapeutics Inc. Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like
US10258738B2 (en) 2004-09-13 2019-04-16 Chrono Therapeutics Inc. Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, AIDs, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like
US11471424B2 (en) 2004-09-13 2022-10-18 Morningside Venture Investments Limited Biosynchronous transdermal drug delivery
AU2006247847B2 (en) * 2005-05-18 2011-05-26 Warner-Lambert Company Llc Flavoring of drug-containing chewing gums
US8658200B2 (en) 2005-05-18 2014-02-25 Mcneil-Ppc, Inc. Flavoring of drug-containing chewing gums
US8323683B2 (en) * 2005-05-18 2012-12-04 Mcneil-Ppc, Inc. Flavoring of drug-containing chewing gums
US20060275344A1 (en) * 2005-05-18 2006-12-07 Seema Mody Flavoring of drug-containing chewing gums
US8709502B2 (en) * 2005-09-23 2014-04-29 Chanel Parfums Beaute Extract of Vanilla planifolia
US20070071710A1 (en) * 2005-09-23 2007-03-29 Chanel Parfums Beaute Extract of vanilla planifolia
US11547660B2 (en) 2006-03-16 2023-01-10 Niconovum Usa, Inc. Snuff composition
US11129792B2 (en) 2006-03-16 2021-09-28 Modoral Brands Inc. Snuff composition
US9402809B2 (en) 2006-03-16 2016-08-02 Niconovum Usa, Inc. Snuff composition
US10219999B2 (en) 2006-03-16 2019-03-05 Niconovum Usa, Inc. Snuff composition
US20100061940A1 (en) * 2006-03-16 2010-03-11 Niconovum Ab Chewing Gum Compositions Providing Rapid Release of Nicotine
US20070269492A1 (en) * 2006-05-16 2007-11-22 Per Steen New product and use and manufacture thereof
US8642016B2 (en) 2006-07-21 2014-02-04 Jsrnti, Llc Medicinal delivery system, and related methods
US10799449B2 (en) 2006-07-21 2020-10-13 Jsrnti, Llc Medicinal delivery system and related methods
US7718677B2 (en) 2007-04-02 2010-05-18 Parkinson's Institute Methods and compositions for reduction of side effects of therapeutic treatments
US20080260825A1 (en) * 2007-04-02 2008-10-23 Maryka Quik Methods and Compositions for Reduction of Side Effects of Therapeutic Treatments
US20100158895A1 (en) * 2007-04-02 2010-06-24 Maryka Quik Methods and compositions for reduction of side effects of therapeutic treatments
US20110077276A1 (en) * 2007-04-02 2011-03-31 Maryka Quik Methods and Compositions for Reduction of Side Effects of Therapeutic Treatments
US20100159004A1 (en) * 2007-04-02 2010-06-24 Maryka Quik Methods and compositions for reduction of side effects of therapeutic treatments
US20100196463A1 (en) * 2007-04-02 2010-08-05 Maryka Quik Methods and compositions for reduction of side effects of therapeutic treatments
US20100166735A1 (en) * 2007-04-02 2010-07-01 Maryka Quik Methods and compositions for reduction of side effects of therapeutic treatments
US20100260690A1 (en) * 2007-09-18 2010-10-14 Arne Kristensen Stable chewing gum compositions comprising maltitol and providing rapid release of nicotine
WO2009141321A2 (en) * 2008-05-21 2009-11-26 Novartis Ag Tablettable chewing gums
WO2009141321A3 (en) * 2008-05-21 2010-10-28 Novartis Ag Tablettable chewing gums comprising nicotine and a buffering agent
US9511021B2 (en) 2008-05-21 2016-12-06 Novartis, A.G. Tablettable chewing gums
US20110129517A1 (en) * 2008-05-21 2011-06-02 Novartis Ag Tablettable chewing gums
US9763929B2 (en) 2008-05-21 2017-09-19 Novartis, A.G. Tablettable chewing gums
US9700525B2 (en) 2008-08-20 2017-07-11 Board Of Supervisors Of Louisiana State University And Agricultural & Mechanical College Continuous local slow-release of therapeutics for head and neck problems and upper aerodigestive disorders
US20110214681A1 (en) * 2008-09-17 2011-09-08 Niconovum Ab Process for preparing snuff composition
US8833378B2 (en) 2008-09-17 2014-09-16 Niconovum Ab Process for preparing snuff composition
US20210045430A1 (en) * 2008-12-19 2021-02-18 U.S. Smokeless Tobacco Company Llc Tobacco granules and method of producing tobacco granules
WO2011139684A2 (en) 2010-04-28 2011-11-10 Niconovum Usa, Inc. Nicotine-containing pharmaceutical compositions
EP3284467A1 (en) 2010-05-07 2018-02-21 Niconovum USA, Inc. Nicotine-containing pharmaceutical compositions
WO2011139811A1 (en) 2010-05-07 2011-11-10 Niconovum Usa, Inc. Nicotine-containing pharmaceutical compositions
US20110318391A1 (en) * 2010-06-28 2011-12-29 Fuisz Richard C Bioactive Dose Having Containing a Material for Modulating pH of a Bodily Fluid to Help or Hinder Absorption of a Bioactive
US8529914B2 (en) * 2010-06-28 2013-09-10 Richard C. Fuisz Bioactive dose having containing a material for modulating pH of a bodily fluid to help or hinder absorption of a bioactive
US10653686B2 (en) 2011-07-06 2020-05-19 Parkinson's Institute Compositions and methods for treatment of symptoms in parkinson's disease patients
US9357801B2 (en) * 2011-10-19 2016-06-07 Fertin Pharma A/S Nicotine chewing gum with improved utilization of nicotine
US20140261505A1 (en) * 2011-10-19 2014-09-18 Vivi Bjerre Jorgensen Nicotine Chewing Gum With Improved Utilization Of Nicotine
WO2013059592A1 (en) 2011-10-21 2013-04-25 Niconovum Usa, Inc. Excipients for nicotine-containing therapeutic compositions
US9907748B2 (en) 2011-10-21 2018-03-06 Niconovum Usa, Inc. Excipients for nicotine-containing therapeutic compositions
EP3744313A1 (en) 2011-10-21 2020-12-02 Modoral Brands Inc. Excipients for nicotine-containing therapeutic compositions
US11925201B2 (en) 2013-03-15 2024-03-12 Altria Client Services Llc Use of pectin or other anionic polymers in the stabilization and controlled release of nicotine in oral sensorial tobacco products or nicotine containing non-tobacco oral sensorial products
US10881134B2 (en) 2013-03-15 2021-01-05 Altria Client Services Llc Use of pectin or other anionic polymers in the stabilization and controlled release of nicotine in oral sensorial tobacco products or nicotine containing non-tobacco oral sensorial products
US10130120B2 (en) 2013-03-15 2018-11-20 Altria Client Services Llc Use of pectin or other anionic polymers in the stabilization and controlled release of nicotine in oral sensorial tobacco products or nicotine containing non-tobacco oral sensorial products
CN110367592A (zh) * 2013-07-19 2019-10-25 奥驰亚客户服务有限责任公司 电子吸烟器具的液体气溶胶制剂
US11154497B2 (en) 2014-06-05 2021-10-26 Per Os Biosciences, Llc Method for manufacturing medicated chewing gum without cooling
US10463612B2 (en) 2014-06-05 2019-11-05 Per Os Biosciences Llc Method for manufacturing medicated chewing gum without cooling
US9744128B2 (en) * 2014-06-05 2017-08-29 Mastix LLC Method for manufacturing medicated chewing gum without cooling
US10232156B2 (en) 2015-01-28 2019-03-19 Chrono Therapeutics Inc. Drug delivery methods and systems
US11400266B2 (en) 2015-01-28 2022-08-02 Morningside Venture Investments Limited Drug delivery methods and systems
US10213586B2 (en) 2015-01-28 2019-02-26 Chrono Therapeutics Inc. Drug delivery methods and systems
US10679516B2 (en) 2015-03-12 2020-06-09 Morningside Venture Investments Limited Craving input and support system
WO2017098443A1 (en) 2015-12-10 2017-06-15 Niconovum Usa, Inc. Protein-enriched therapeutic composition of a nicotinic compound
US11311623B2 (en) 2016-04-21 2022-04-26 Fertin Pharma A/S Nicotine delivery product, related uses and oral dosage forms, and methods of production
EP3445344B1 (en) 2016-04-21 2020-08-19 Fertin Pharma A/S Nicotine delivery product, related uses and oral dosage forms, and methods of production
US11077089B2 (en) 2016-06-22 2021-08-03 Per Os Biosciences, Llc Oral compositions delivering therapeutically effective amounts of cannabinoids
US11285306B2 (en) 2017-01-06 2022-03-29 Morningside Venture Investments Limited Transdermal drug delivery devices and methods
US11596779B2 (en) 2018-05-29 2023-03-07 Morningside Venture Investments Limited Drug delivery methods and systems
WO2019239356A1 (en) 2018-06-15 2019-12-19 R. J. Reynolds Tobacco Company Purification of nicotine
CN112367978A (zh) * 2018-07-13 2021-02-12 麦克内尔股份公司 包含尼古丁的口香糖
CN108991596A (zh) * 2018-10-11 2018-12-14 玉溪开元金蓝生物科技有限责任公司 复方滇橄榄添加料、制备方法及其在香烟滤嘴棒上的应用
CN114945359A (zh) * 2020-01-15 2022-08-26 麦克内尔股份公司 口香糖的产品和制备方法

Also Published As

Publication number Publication date
RU2003137595A (ru) 2005-02-10
JP2005500296A (ja) 2005-01-06
BR0210342A (pt) 2004-07-13
WO2002102357A1 (en) 2002-12-27
DE60238054D1 (de) 2010-12-02
CA2449298C (en) 2011-08-02
EP1404306A1 (en) 2004-04-07
IL159425A (en) 2006-12-10
AU2002345454B2 (en) 2006-07-20
JP4571402B2 (ja) 2010-10-27
RU2291688C2 (ru) 2007-01-20
SE0102197D0 (sv) 2001-06-20
ATE485034T1 (de) 2010-11-15
ES2352681T3 (es) 2011-02-22
ZA200309204B (en) 2005-02-23
CZ20033458A3 (en) 2004-05-12
DK1404306T3 (da) 2011-01-24
AR034527A1 (es) 2004-02-25
JP2010070564A (ja) 2010-04-02
NZ529780A (en) 2006-04-28
MXPA03011557A (es) 2004-03-18
EP1404306B1 (en) 2010-10-20
CA2449298A1 (en) 2002-12-27
US20120017924A1 (en) 2012-01-26
IL159425A0 (en) 2004-06-01

Similar Documents

Publication Publication Date Title
AU2002345454B2 (en) A coated nicotine-containing chewing gum, manufacture and use thereof
CA2652500C (en) Coated pharmaceutical product for intraoral delivery of nicotine comprising trometamol as buffering agent
AU2007250588B2 (en) Pharmaceutical product for intraoral delivery of nicotine comprising trometamol as buffering agent
US20080286341A1 (en) Buffered coated nicotine containing products
AU2002345454A1 (en) A coated nicotine-containing chewing gum, manufacture and use thereof
AU2008251095B2 (en) Oral nicotine formulation buffered with amino acid
WO2018219650A1 (en) Nicotine-containing chewing gum compositions

Legal Events

Date Code Title Description
AS Assignment

Owner name: PHARMACIA AB, SWEDEN

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:LINDELL, KATARINA;LINDBERG, NILS-OLOF;OLSSON, ROLAND;REEL/FRAME:015451/0395;SIGNING DATES FROM 20040130 TO 20040204

AS Assignment

Owner name: MCNEIL AB, SWEDEN

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:PHARMACIA AB;PFIZER HEALTH AB;REEL/FRAME:020217/0254;SIGNING DATES FROM 20000928 TO 20061201

Owner name: MCNEIL AB, SWEDEN

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:PHARMACIA AB;PFIZER HEALTH AB;SIGNING DATES FROM 20000928 TO 20061201;REEL/FRAME:020217/0254

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION